» Articles » PMID: 20164060

Dual-color Proteomic Profiling of Complex Samples with a Microarray of 810 Cancer-related Antibodies

Abstract

Antibody microarrays have the potential to enable comprehensive proteomic analysis of small amounts of sample material. Here, protocols are presented for the production, quality assessment, and reproducible application of antibody microarrays in a two-color mode with an array of 1,800 features, representing 810 antibodies that were directed at 741 cancer-related proteins. In addition to measures of array quality, we implemented indicators for the accuracy and significance of dual-color detection. Dual-color measurements outperform a single-color approach concerning assay reproducibility and discriminative power. In the analysis of serum samples, depletion of high-abundance proteins did not improve technical assay quality. On the contrary, depletion introduced a strong bias in protein representation. In an initial study, we demonstrated the applicability of the protocols to proteins derived from urine samples. We identified differences between urine samples from pancreatic cancer patients and healthy subjects and between sexes. This study demonstrates that biomedically relevant data can be produced. As demonstrated by the thorough quality analysis, the dual-color antibody array approach proved to be competitive with other proteomic techniques and comparable in performance to transcriptional microarray analyses.

Citing Articles

Proteome Analysis for Inflammation Related to Acute and Convalescent Infection.

Sigdel T, Sur S, Boada P, McDermott S, Arlehamn C, Murray K Inflammation. 2023; 47(1):346-362.

PMID: 37831367 PMC: 10799112. DOI: 10.1007/s10753-023-01913-3.


Discovery and systematic assessment of early biomarkers that predict progression to severe COVID-19 disease.

Hufnagel K, Fathi A, Stroh N, Klein M, Skwirblies F, Girgis R Commun Med (Lond). 2023; 3(1):51.

PMID: 37041310 PMC: 10089829. DOI: 10.1038/s43856-023-00283-z.


Proteomic analysis of peritoneal fluid identified COMP and TGFBI as new candidate biomarkers for endometriosis.

Jansa V, Klancic T, Pusic M, Klein M, Vrtacnik Bokal E, Ban Frangez H Sci Rep. 2021; 11(1):20870.

PMID: 34686725 PMC: 8536751. DOI: 10.1038/s41598-021-00299-2.


Novel voltammetric tumor necrosis factor-alpha (TNF-α) immunosensor based on gold nanoparticles involved in thiol-functionalized multi-walled carbon nanotubes and bimetallic Ni/Cu-MOFs.

Yola M, Atar N Anal Bioanal Chem. 2021; 413(9):2481-2492.

PMID: 33544162 DOI: 10.1007/s00216-021-03203-z.


Three-Color Imaging Enables Simultaneous Screening of Multiple RNA Targets on Small Molecule Microarrays.

Jordan D, Yang M, Schneekloth Jr J Curr Protoc Chem Biol. 2020; 12(4):e87.

PMID: 33275330 PMC: 10795844. DOI: 10.1002/cpch.87.


References
1.
Notterman D, Alon U, Sierk A, Levine A . Transcriptional gene expression profiles of colorectal adenoma, adenocarcinoma, and normal tissue examined by oligonucleotide arrays. Cancer Res. 2001; 61(7):3124-30. View

2.
Taussig M, Stoevesandt O, Borrebaeck C, Bradbury A, Cahill D, Cambillau C . ProteomeBinders: planning a European resource of affinity reagents for analysis of the human proteome. Nat Methods. 2006; 4(1):13-7. DOI: 10.1038/nmeth0107-13. View

3.
Ekins R . Ligand assays: from electrophoresis to miniaturized microarrays. Clin Chem. 1998; 44(9):2015-30. View

4.
Loch C, Ramirez A, Liu Y, Sather C, Delrow J, Scholler N . Use of high density antibody arrays to validate and discover cancer serum biomarkers. Mol Oncol. 2009; 1(3):313-20. PMC: 2671017. DOI: 10.1016/j.molonc.2007.08.004. View

5.
Zhao Y, Lee W, Xiao G . Quantitative proteomics and biomarker discovery in human cancer. Expert Rev Proteomics. 2009; 6(2):115-8. PMC: 2835852. DOI: 10.1586/epr.09.8. View